SILANES Trademark

Trademark Overview


On Thursday, October 3, 1996, a trademark application was filed for SILANES with the United States Patent and Trademark Office. The USPTO has given the SILANES trademark a serial number of 75176361. The federal status of this trademark filing is REGISTERED AND RENEWED as of Tuesday, May 21, 2019. This trademark is owned by LABORATORIOS SILANES, S.A. DE C.V.. The SILANES trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceuticals, namely, injectable solutions, tablets, pills and capsules for adults and children, oral suspension, medicated syrup and ointment, all for treatment as a cough suppressant, and expectorant, [ activity against anaerobic bacteria, Trichomona vaginalis, Entamoeba histolytica, and giardia lamblia, ] as an antifungal agent for treatment of Oropharyngeal and esophageal candidiasis, [ candidial urinary tract infections, peritonitis and systemic candidal infections, candidemia, disseminated candidiasis and pneumonia, cryptococcal meningitis, candidal genital tract infections, ] as an analgesis anti-inflamatory non steroidal inhibitor of prostaglandin synthetase, [ analgesic and minor tranquilizer, active immunization against tetanus, peripheral neuritis, neuralgias, peripheral neuritis, neuralgias and haematopoietic, antifungal agent for treatment of systemic blastomycosis, histoplasmosis paracoccidloidomycosis, fungal infection of the gastrointestinal tract and tinea infection...
silanes

General Information


Serial Number75176361
Word MarkSILANES
Filing DateThursday, October 3, 1996
Status800 - REGISTERED AND RENEWED
Status DateTuesday, May 21, 2019
Registration Number2241440
Registration DateTuesday, April 27, 1999
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, September 22, 1998

Trademark Statements


Goods and Servicespharmaceuticals, namely, injectable solutions, tablets, pills and capsules for adults and children, oral suspension, medicated syrup and ointment, all for treatment as a cough suppressant, and expectorant, [ activity against anaerobic bacteria, Trichomona vaginalis, Entamoeba histolytica, and giardia lamblia, ] as an antifungal agent for treatment of Oropharyngeal and esophageal candidiasis, [ candidial urinary tract infections, peritonitis and systemic candidal infections, candidemia, disseminated candidiasis and pneumonia, cryptococcal meningitis, candidal genital tract infections, ] as an analgesis anti-inflamatory non steroidal inhibitor of prostaglandin synthetase, [ analgesic and minor tranquilizer, active immunization against tetanus, peripheral neuritis, neuralgias, peripheral neuritis, neuralgias and haematopoietic, antifungal agent for treatment of systemic blastomycosis, histoplasmosis paracoccidloidomycosis, fungal infection of the gastrointestinal tract and tinea infections of the skin, and nails, sulphonylurea and biguanide, hipoglycaemic agent, activity against trichomonas vaginalis, entamoeba histolytica and Giardia lamblia, anaerobic bacteria, ] histamine H1-receptor antagonist and prophylactic treatment of asthma, and treatment of allergic conditions such as rhinitis and conjuntivitis,[ analgesic, ] anti-inflamatory non steroidal, for inhibiting prostaglanding synthetase, [ analgesic, anti-inflammatory non steroidal, inhibitor of prostaglandin synthetase ] and muscle relaxant, analgesic, antipyretic, [ sulphonylurea hipoglycaemic agent, for inhibiting as an angiotensin-converting enzyme, treatment of congestive heart failure and asymptomatic left ventricular dysfunction, diuretic treatment of congestive heart failure, hypertension, cardiac, renal hepatogenic oedema, peripheral neuritis, neuralgias and analgesic, ] a broad spectrum antibiotic, effective against a wide range of Gram positive and Gram negative aerobic and anaerobic bacterias, [ histamin H2-receptor antagonist in the treatment of gastric an duodenal ulcer, Zollinger-Ellison syndrome, iron deficiency and anemia for children or adults, ] anixolytic, anticonvulsant, sedative, muscle relaxant, [ histamine H2-receptor antagonist in the treatment of gastric and duodenal ulcer Zollinger-Ellison syndrome, ] multivitamin treatment and prevention of vitamin B1-B6-B12 deficiency, [ tricyclic antidepressant, treatment of nocturnal enuresis in children, inhibits angiotensin-converting enzyme, ] treatment of hypertension and congestive heart failure, treatment and prevention of vitamic C deficiency, treatment and prevention of seborrhoea and dandruff, analgesic no narcotic

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, October 28, 1996
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameLABORATORIOS SILANES, S.A. DE C.V.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCiudad de México 11000
MX

Party NameLABORATORIOS SILANES, S.A. DE C.V.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMexico City
MX

Party NameLABORATORIOS SILANES, S.A. DE C.V.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMexico City
MX

Trademark Events


Event DateEvent Description
Saturday, April 23, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Saturday, April 23, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Saturday, April 23, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, January 16, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, January 16, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, May 21, 2019NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Tuesday, May 21, 2019REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
Tuesday, May 21, 2019REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Monday, May 20, 2019CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, April 16, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, April 16, 2019TEAS SECTION 8 & 9 RECEIVED
Friday, April 27, 2018COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Thursday, February 26, 2009REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Thursday, February 26, 2009REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Thursday, February 19, 2009TEAS SECTION 8 & 9 RECEIVED
Friday, July 13, 2007CASE FILE IN TICRS
Friday, December 30, 2005REGISTERED - SEC. 8 (6-YR) ACCEPTED
Thursday, October 27, 2005REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
Thursday, October 27, 2005TEAS SECTION 8 RECEIVED
Tuesday, April 27, 1999REGISTERED-PRINCIPAL REGISTER
Thursday, October 29, 1998Sec. 1(B) CLAIM DELETED
Monday, March 15, 1999NOTICE OF ALLOWANCE CANCELLED
Tuesday, December 15, 1998NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 22, 1998PUBLISHED FOR OPPOSITION
Friday, August 21, 1998NOTICE OF PUBLICATION
Monday, July 20, 1998APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, July 20, 1998PREVIOUS ALLOWANCE COUNT WITHDRAWN
Friday, July 17, 1998JURISDICTION RESTORED TO EXAMINING ATTORNEY
Friday, July 17, 1998EX PARTE APPEAL-INSTITUTED
Thursday, July 9, 1998APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, May 18, 1998CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, November 18, 1997FINAL REFUSAL MAILED
Tuesday, October 14, 1997CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, April 12, 1997NON-FINAL ACTION MAILED
Tuesday, April 8, 1997ASSIGNED TO EXAMINER